These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34536299)

  • 1. Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials.
    Neiheisel A; Kaur M; Ma N; Havard P; Shenoy AK
    Int J Cancer; 2022 Mar; 150(5):727-740. PubMed ID: 34536299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt/beta-catenin pathway: modulating anticancer immune response.
    Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
    J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on the role of Wnt biology in cancer.
    Mirabelli CK; Nusse R; Tuveson DA; Williams BO
    Sci Signal; 2019 Jul; 12(589):. PubMed ID: 31289213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics.
    Harb J; Lin PJ; Hao J
    Curr Oncol Rep; 2019 Feb; 21(2):12. PubMed ID: 30715618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.
    Shah K; Panchal S; Patel B
    Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the WNT Signaling Pathway in Cancer Therapeutics.
    Tai D; Wells K; Arcaroli J; Vanderbilt C; Aisner DL; Messersmith WA; Lieu CH
    Oncologist; 2015 Oct; 20(10):1189-98. PubMed ID: 26306903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy.
    Song P; Gao Z; Bao Y; Chen L; Huang Y; Liu Y; Dong Q; Wei X
    J Hematol Oncol; 2024 Jun; 17(1):46. PubMed ID: 38886806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons.
    Mukherjee N; Panda CK
    Clin Breast Cancer; 2020 Oct; 20(5):361-370. PubMed ID: 32416986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular strategies for modulating Wnt signaling.
    Gustafson CT; Mamo T; Maran A; Yaszemski MJ
    Front Biosci (Landmark Ed); 2017 Jan; 22(1):137-156. PubMed ID: 27814607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
    Cheng X; Xu X; Chen D; Zhao F; Wang W
    Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer.
    Liu Z; Wang P; Wold EA; Song Q; Zhao C; Wang C; Zhou J
    J Med Chem; 2021 Apr; 64(8):4257-4288. PubMed ID: 33822624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of noncanonical Wnt signaling in cancers.
    Chen Y; Chen Z; Tang Y; Xiao Q
    Biomed Pharmacother; 2021 Jan; 133():110946. PubMed ID: 33212376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Zhang Y; Wang X
    J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of targeting Wnt/β-catenin in colon cancer.
    Sebio A; Kahn M; Lenz HJ
    Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Wnt/β-catenin signal pathway for the treatment of gastrointestinal cancer: Potential for advancement.
    Jin X; Wang S; Luo L; Yan F; He Q
    Biochem Pharmacol; 2024 Sep; 227():116463. PubMed ID: 39102994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase.
    Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A
    Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
    Dzobo K; Thomford NE; Senthebane DA
    OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors.
    Ferri M; Liscio P; Carotti A; Asciutti S; Sardella R; Macchiarulo A; Camaioni E
    Eur J Med Chem; 2017 Dec; 142():506-522. PubMed ID: 29107427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities.
    Xu X; Zhang M; Xu F; Jiang S
    Mol Cancer; 2020 Nov; 19(1):165. PubMed ID: 33234169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.
    Vallée A; Lecarpentier Y; Vallée JN
    Cells; 2019 Jul; 8(7):. PubMed ID: 31311204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.